Skip to main content
Caplight Logo









RNA NanoBiotics, Inc.

RNA NanoBiotics, Inc.

Private
Columbus, OhioHealthcare & Life Scienceshttps://rna-nano.com/

Last Round

VC Round

Jan 1, 2025

Company Overview

RNA NanoBiotics, Inc. is a biotechnology company that develops nanoparticle-based drug delivery systems for targeted cancer therapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

nanoparticle deliveryRNA therapeuticsdrug delivery platformbiotechnology R&Dnucleic acid medicinemRNA vaccinesgene therapydrug delivery techbiotech licensingpreclinical researchnanomedicinedrug delivery systemsbiopharma partnershiptargeted delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RNA NanoBiotics, Inc. Comparables

Compare RNA NanoBiotics, Inc. with similar companies based on industry and business-model similarity.

RNA NanoBiotics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RNA Nanotherapeutics
87%
NanoVation Therapeutics
84%
Entos Pharmaceuticals
82%

RNA NanoBiotics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 1, 2025

Key People

Founding team and executive leadership

James Carroll

President and Chief Executive Officer

Executive Team

RNA NanoBiotics, Inc. Investors

Notable investors and investment history

RNA NanoBiotics, Inc. investors
InvestorRounds
Symbiotic VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors grew 4120% MoM, from 25 to 1.1K.

  • Apr 6, 2026

    Monthly visitors increased 1204% from 25 to 326.

RNA NanoBiotics, Inc. Filings

Explore SEC and related filing metadata, where available.

RNA NanoBiotics, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RNA NanoBiotics, Inc.'s valuation, stock price, and market status.

Is RNA NanoBiotics, Inc. a public or private company?

RNA NanoBiotics, Inc. is a private company.

What is the current stock price of RNA NanoBiotics, Inc.?

RNA NanoBiotics, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is RNA NanoBiotics, Inc. worth (valuation)?

Valuation information for RNA NanoBiotics, Inc. is not publicly available.

Can I buy RNA NanoBiotics, Inc. stock?

RNA NanoBiotics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RNA NanoBiotics, Inc.'s last funding round?

RNA NanoBiotics, Inc.'s most recent funding round was VC Round on January 1, 2025.

Who are the main investors in RNA NanoBiotics, Inc.?

Key investors in RNA NanoBiotics, Inc. include Symbiotic Ventures.

Will RNA NanoBiotics, Inc. IPO soon?

No public IPO plans have been announced for RNA NanoBiotics, Inc..

How can I track RNA NanoBiotics, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RNA NanoBiotics, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersColumbus, Ohio
Employee Range3
Year Founded2024
Last FundingJan 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?